Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. [electronic resource]
Producer: 20090611Description: 639-48 p. digitalISSN:- 1876-7605
- Acute Coronary Syndrome -- blood
- Adult
- Aged
- Aged, 80 and over
- Angioplasty, Balloon, Coronary -- adverse effects
- Anticoagulants -- administration & dosage
- Clopidogrel
- Coronary Angiography
- Drug Administration Schedule
- Drug Therapy, Combination
- Female
- Hemorrhage -- chemically induced
- Heparin -- administration & dosage
- Hirudins -- administration & dosage
- Humans
- Male
- Middle Aged
- Myocardial Infarction -- etiology
- Peptide Fragments -- administration & dosage
- Platelet Aggregation Inhibitors -- administration & dosage
- Platelet Glycoprotein GPIIb-IIIa Complex -- antagonists & inhibitors
- Recombinant Proteins -- administration & dosage
- Risk Assessment
- Thrombosis -- blood
- Ticlopidine -- administration & dosage
- Time Factors
- Treatment Outcome
- Troponin -- blood
- Young Adult
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.